B.C. study finds low but increased risk of myocarditis after 2nd Moderna COVID shotLead author Dr. Naveed Janjua said the findings related to second doses for both vaccines show men between the ages of 18 and 29 are most at risk of myocarditis if they received Moderna's COVID-19 vaccine. Smartphone potential harborers of significant allergens: studyThose with allergies and asthma advised to clean phones more often to avoid triggers Examining sexual activity as an asthma trigger Equivalent to walking up two flights of stairs, but its impact may be underreported. New combination treatments offer hope to cat allergy sufferers Research out of UCLA shows adding monoclonal antibody treatments to immunotherapy diminishes cat allergies more than allergy shots alone. OPENPediatrics creates playlist of resources on children and RSV The open access online community of healthcare professionals seeks to share resources to promote best practices in clinical pediatrics. Europe OKs 1st one dose drug to protect babies against RSV At the moment, babies at high risk of the disease can be given monthly shots to protect them during RSV season. Tezspire now available for add-on maintenance treatment of severe asthma First biologic for severe asthma targeting thymic stromal lymphopoietin is effective regardless of phenotype. Breztri Aerosphere now available for long-term maintenance treatment of COPD Second 'triple-therapy' combination product approved in Canada for COPD maintenance treatment to reduce exacerbations and treat airflow obstruction. A connection between antihistamines and opioid overdose? Recent findings from a CDC report suggest diphenhydramine—the active ingredient in many common antihistamines—may be a hidden risk. WHO: Tuberculosis cases rise for the first time in years The U.N. health agency said more than 10 million people worldwide were sickened by tuberculosis in 2021, a 4.5% rise from the year before. First Previous 14 15 16 17 18 Next Last
